Health Canada Special Access Program

Canada Approves Legal Medical Psilocybin Access For Veteran, To Undergo Apex's Macrodose Therapy (CORRECTED)
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations

Health Canada Special Access Program Recent News

Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products
Life sciences biotech company Core One Labs Inc. (OTCQB: CLABF) signed a Letter of Intent with GMP-certified manufacturer Medelys Laboratories International Inc. for the manufacturing of its proprietary psychedelic active pharmaceutical ingredient (API) products.
Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic
Legal ketamine-assisted therapy for people with diagnosed mental health conditions continues to expand throughout the U.S. and Canada. 
Toronto Residents Get New Ketamine-Assisted Therapy Option Close To Home
The Neurology Centre of Toronto (NCT), located in a midtown neighborhood and owned by Numinus Wellness Inc. (OTCQX: NUMIF), is offering ketamine-assisted therapy for patients with neurologic conditions diagnoses.
What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture
Optimi Health Corp.
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC: HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its therapeutic retreats in Jamaica and Optimi Health Corp.
Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment.
Braxia Opens New Clinic in Ontario, Facilitating Further Access To Ketamine And Psilocybin Treatments
Braxia Scientific Corp.